Microsoft word - wright cv - website version.doc

Curriculum
Scott A. Wright, MD, FACC
Practice
Center for Medical Weight Loss of East Texas, Medical Director Cardiovascular Associates of East Texas, P.A., Tyler, Texas Affiliation
Education
University of Texas Medical Branch at Galveston Bachelor of Science (Major: Bioengineering) University of Texas Medical Branch at Galveston University of Texas Medical Branch at Galveston Board Certification
American Board of Internal Medicine – Cardiovascular Disease
Licensure
Nuclear Radiation Certification State of Texas #L04800 Texas State Board of Medical Examiners #K9950
Hospital Appointments
East Texas Medical Center, Tyler, Texas
East Texas medical Center, Athens, Texas
East Texas Medical Center, Carthage, Texas
East Texas Medical Center, Jacksonville, Texas
Trinity Mother Frances Hospital, Tyler, Texas
Titus Regional Medical Center, Mount Pleasant, Texas
Professional Societies/Memberships

Research
Co-Investigator – Paradigm - A multicenter, randomized, double-blind, parallel group, active-controlled
study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in
patients with chronic heart failure and reduced ejection fraction.
Co-Investigator - XIENCE™ V: Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval
Study sponsored by Abbott Vascular Inc.

Investigator – MUSIC – Multi-Sensor Monitoring in Congestive Heart Failure Study.
Investigator – RECORD AF – REgistry on Cardiac rhythm disORDers: an international, observational,
prospective survey assessing the control of Atrial Fibrillation.
Co-Investigator – RE-LY - Randomized Evaluation of Long term anticoagulant therapy (RE-LY) comparing
the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for the
prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective,
multi-centre, parallel-group, non-inferiority trial.
Co-Investigator – ENDEAVOR IV – A Randomized, Controlled Trial of the Medtronic Endeavor Drug Eluting
Coronary Stent System versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native
Coronary Artery Lesions.
Co-Investigator – A-HeFT - A Placebo-Controlled Trial of Bidil Added to Standard Therapy In African-
American Patients with Heart Failure.
Co-Investigator - ACCOMPLISH- A prospective, multicenter, double-blind, randomized, active-controlled
trial to compare the effects of Lotrel (amlodipine/benazepril to benazepril and hydrochlorothiazide
combined on the reduction of cardiovascular morbidity and mortality in patients with high risk
hypertension.
Co-Investigator - AMIHOT II – A prospective, Multi-center, randomized study of Aqueous Oxygen Therapy
for 90 minutes in Anterior Acute MI patients with successful PCI/stenting presenting within 6 hours from
time of symptom onset until time of reperfusion.
Co-Investigator – TIMI38/TRITON – A Comparison of CS-747 and Clopidrogrel in Acute Coronary
Syndrome Patients who are to Undergo Percutaneous Coronary Intervention; a Phase III, multicenter,
randomized, parallel-group, double-dummy, active controlled trial in patients with acute coronary
syndrome (ACS), who are to undergo percutaneous coronary intervention (PCI).
Co-Investigator – VISION 305 Study - “Vasodilator Induced Stress In Concordance with Adenosine” A
multicenter, risk-stratified, randomized, double-blind, double-dummy study drug administration, active-
controlled, complete two-arm crossover study with a reference third arm.
Co-Investigator - APEX-AMI Study - “A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-
Control ed Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary
Percutaneous Coronary Intervention.” (Assessment of PEXelizumab in Acute Myocardial Infarction)-APEX-
AMI.
Co-Investigator - XIENCE™ V: Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval
Study sponsored by Abbott Vascular Inc.

High Frequency Electrocardiograms versus Standard Electrocardiograms in Acute Coronary Syndromes:
assessing improved sensitivity of HF-EKG in multiple clinical scenarios including adenosine stress testing,
percutaneous interventions, risk stratification in emergency departments. Study done in conjunction with
NASA.
Retrospective Analysis of Adenosine Perfusion Studies in Prediction of Coronary Artery Disease:
Comparing results of adenosine perfusion studies with documented coronary anatomy by cardiac
catheterization.
Masters Thesis, Roger S. Walker, Ph.D.
University of Texas at Arlington, Department of Computer Science
Developed high resolution laser measurement system for Texas Highway Department
Graduate Research Assistant, Roger S. Walker, Ph.D. University of Texas at Arlington, Department of Computer Science Studied feasibility and software modeling of laser systems. Co-Investigator – SYNERGY - A Prospective, Randomized, Open-Label, Multicenter Study in Patients Presenting with Acute Coronary Syndromes Aventix Pharmaceuticals Protocol Number ENO.GMA.301. IND# 31532 Co-Investigator – A Double-Blind Comparison Of The Incidence Of Hypotension With Two Formulations Of Intravenous Amiodarone: Cordarone・ I.V. vs Amiodarone Aqueous I.V. Injection - Protocol No. 058K1-312-US Co-Investigator – Otsuka Protocol 21-98-214-01 CASTLE “ A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Arm, Study to Assess The Long-Term Effects of Pletal® (Cilostazol) Versus Placebo Administered Orally to Patients with Intermittent Claudication Secondary to Peripheral Arterial Disease Co-Investigator – AMIHOT – TherOx Aqueous Oxygen System – Acute Myocardial Infarction with Hyperoxemic Therapy “AMIHOT” Phase II clinical trial. A Randomized, Controlled, Multicenter Trial of Aqueous Oxygen Infusion for 90 Minutes Post-Primary PTCA/Stent Intervention in Acute Myocardial Infarction Patients. Co-Investigator – A Multicenter, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients with Stable Angina. Co-Investigator – Extra Point. Protocol # S1710202. Cardiovascular Safety Study of Nicotine Transdermal System

Source: http://www.texasheartdoctors.com/pdf/wright-CV.pdf